Portrait of Sugandha Asthana

Microbiologist — Science Communicator — Founder, Simplify-Research

Sugandha Asthana, Ph.D

I make dense science make sense.

I spent seven years buried in academic papers — microbial research, biofuel development, the whole grind of scientific publishing. Somewhere in there I realized the hardest part wasn't doing the science, it was getting anyone outside the lab to actually read it. So I built Simplify-Research to fix that at scale, and I've been writing, reviewing, and talking about science ever since. Below: the tool, the papers I've written myself, and a few of the conversations along the way.

Based inPennsylvania
Ph.D.Biotechnology, Amity University
FieldMicrobial science, biofuels

Founder

Simplify-Research

An AI tool that turns a dense academic PDF into structured, plain-English insight.

Decode research. Accelerate discovery.

One upload returns a paper summary, an ELI15 breakdown, a technical deep-dive, an impact scorecard, a research roadmap, and a methodology flow diagram — plus a branded PDF export a reader can save or forward.

5 views
summary · technical · impact · roadmap · flow
live now
launched april 2026
Animated demo cycling through all five Simplify-Research dashboard views: summary, technical, impact, roadmap, and flow

Real output, cycling through all 5 views — source paper: Chen et al., "The Genome Sequence Archive Family," Genomics, Proteomics & Bioinformatics, 2021 ↗ (open access)

Every analysis exports as a branded report

Not just a summary on screen — a clean, citable PDF a reader can save, print, or forward, with the same structure as the dashboard view.

↓ Download the full PDF report

Written by me

Original science writing

Three pieces, three corners of biology — a developmental disorder, an autoimmune rarity, and the microbes that shouldn't be alive at all.

Neurology

Beyond Movement: Understanding Cerebral Palsy from Cause to Cure

Cerebral palsy (CP) is a neurodevelopmental disorder that affects different parts of the brain in neonates. For a very long time, it was thought that this condition arose due to delivery complications, including delayed delivery, premature birth, and hypoxic conditions generated during delivery. Still, even after managing these conditions, the incidence rate didn't decrease significantly. Multiple studies and years later, it was observed that CP is not just a perinatal condition but also antenatal and postnatal. In antenatal care, the mother's health is crucial. If the mother has any infectious disease, such as CMV, rubella, toxoplasmosis, or Zika virus, it can penetrate the placental barrier and infect the baby, resulting in CP. Other conditions such as diabetes, hypertension and thyroid conditions can also increase the risk of CP. Apart from this, CP also develops due to chromosomal mutations and epigenetic modifications.

Symptoms of CP depend on which area of the brain is affected. The cortex is affected in spastic CP, resulting in increased muscle tone and increased reflexes. In dyskinetic CP, the basal ganglia are affected, causing involuntary, uncontrolled and repetitive movements with fluctuating muscle tone. Ataxic CP occurs when the cerebellum is affected, causing loss of coordination with hypotonia. In most cases, spastic CP is common, but in some cases, different brain regions are affected, resulting in mixed CP with a wide array of symptoms.

With advances in treatments, including therapies and medicines, most symptoms of CP can be managed. Novel treatment ideas such as glial cell transplantations, nanomedicine and stem cell therapy are under investigation and hold a bright future. Neurogenerative therapies are also being researched. The goal of these studies is to replace lost or injured brain tissue to restore its structure and function. These studies are in the experimental phase and face numerous difficulties, including problems with safety, efficacy and ethics.

Many individuals with CP have achieved fame as actors, writers, activists and comedians. This condition might be limiting, but it certainly isn't limitless.

References

  1. Albright, A. L. (2023). Spasticity and movement disorders in cerebral palsy. Child's Nervous System, 39(10), 2877–2886. https://doi.org/10.1007/s00381-023-06045-5
  2. Mayo Clinic Staff. (2023, September 28). Cerebral palsy – Symptoms and causes. Mayo Clinic.
  3. Paul, S., Nahar, A., Bhagawati, M., & Kunwar, A. J. (2022). A review on recent advances of cerebral palsy. Oxidative Medicine and Cellular Longevity, 2022, Article 2622310.
  4. Sadowska, M., Sarecka-Hujar, B., & Kopyta, I. (2020). Cerebral palsy: Current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatric Disease and Treatment, 16, 1505–1518.
  5. Vova, J. (2022). Cerebral palsy: An overview of etiology, types and comorbidities. OBM Neurobiology, 6(2).
Autoimmune

Stiff Person Syndrome: When Your Body Attacks Its Own Framework

With the hardships faced by women in their everyday life, one would think that at least their bodies would be in support, but that's not so! Stiff Person Syndrome affects women twice as much as men. Although this disorder is so rare that it is seen in 1 in 1 million people, women are still not spared!

This rare condition is caused when antibodies are formed against Glutamic Acid Decarboxylase (GAD), the rate-limiting enzyme for the synthesis of the inhibitory gamma-aminobutyric acid (GABA). This amino acid is an inhibitory neurotransmitter of the brain, which prevents misfiring of neurons and maintains muscle movement. With antibodies against GABA, the first symptoms observed in patients occur in the form of leg stiffness. This stiffness carries upwards and reaches the spinal cord, causing spasms. A person suffering from this condition has difficulty bending, which is referred to as Tin-Man syndrome. Another unique symptom observed in these patients is that they are sensitive to noise triggers. A loud noise in any form — music, loud banging, honking — results in the triggering of spasms in all the affected muscles.

This disease has been misdiagnosed because it falls under numerous other disorders called GABA disorders, the most common being neuropathy and myelopathy. This misdiagnosis results in delaying or even wrong treatment. Numerous studies are underway to distinguish this condition from other diseases and are focusing solely on its physical symptoms. Unfortunately, there is no cure, and symptomatic relief is given to patients via benzodiazepines, baclofen, and other GABAergic agents. This enhances GABAergic neurotransmission, relieving muscle stiffness and spasms. Other treatment plans involve immunomodulatory treatments (e.g., IVIg, plasmapheresis, rituximab) aimed at modifying the underlying autoimmune response.

The human body is an enigma; the cells that are supposed to protect end up hurting us the most! Such a rare autoimmune disorder caught the eyes of researchers, and improvement in diagnosis is still underway. Since the cohort size is small, patients do end up suffering because of misdiagnosis. But one should never give up hope. With the advent of gene therapy, maybe there is a brighter future for all of them.

References

  1. Dalakas, M. C. (2022). Stiff-person syndrome and GAD antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies. Neurotherapeutics, 19(3), 832–847.
  2. Roy, S., Huang, Y., Hu, C., Fitzgerald, K. C., Wang, Y., & Newsome, S. D. (2025). Core diagnostic features of stiff person syndrome: insights from a case-control study. J Neurol, 272(5), 377.
  3. Lenglet, T., Honnorat, J., & Attarian, S. (2025). Systematic review of immune and symptomatic treatments for stiff-person syndrome. European Journal of Neurology, 32(11), e70435.
Microbiology

The Adventurous Creature of Microbiology: Extremophiles!

The winter in the United States was brutal this year. With the snowstorms, chilly winds, and extreme temperatures, going outside seemed like a thing of the past! It felt like I was back in 2020 and there was a lockdown in place. Days after days of never-ending snow where even the trees struggled to survive, I noticed something growing on the walls of my balcony. What can grow when even breathing hurts? Turns out it was a type of mold! Welcome to the world of extreme adventures, where only one thing survives: Extremophiles!

Extremophiles are organisms that can live in extreme climatic conditions and are termed as follows:

TypeConditionExamples
ThermophilesHigh temperaturesThermus aquaticus, Pyrococcus furiosus
PsychrophilesLow temperaturesMoraxella sp., Flavobacterium sp.
HalophilesHigh salinity (2–6M NaCl)Halobacterium, Haloferax
AcidophilesLow pH (<3)Penicillium sp., Sulfolobus solfataricus
AlkaliphilesHigh pH (>9)Alkalibacillus sp.
RadiophilesHigh radiationPorphyra rosengurttii, Deinococcus radiodurans

Extremophiles are very smart and are able to thrive in extreme conditions because of modified cell membranes, strong DNA repair mechanisms, and very stable enzymes, which help them withstand high pressure, high temperature, and high salt concentration.

In thermophiles, it has been observed that there are an abundance of tyrosine, glutamate, and leucine, which favors ionic interactions, rigidity, and hydrophobicity. The opposite is true for psychrophiles, which are abundant in amino acids such as threonine, methionine, phenylalanine, and serine. Thermophiles also have a very robust DNA polymerase that retains its stability at high temperatures. You would have used these polymerases in your work as well: Taq polymerase (from Thermus aquaticus) and Pfu polymerase (from Pyrococcus furiosus).

Other than its uses in the laboratory, various extremophiles are being used in biotechnology industries. An ongoing study by H. Abdulsalam focuses on using radiophiles to generate microbial fuel cells, which would be operative in high-radiation conditions. This can aid in space exploration and nuclear waste management! Imagine the power of such a small creature!

Uses of extremophiles are being explored across industries, including food, biomedical, and cosmetic. Although there are multiple processing and low-yield challenges, these small creatures hold much power and will help in advancing science!

References

  1. Jin, M., et al. (2019). Properties and applications of extremozymes from deep-sea extremophilic microorganisms: a mini review. Mar. Drugs, 17, 656.
  2. Sysoev, M., et al. (2021). Bioprospecting of novel extremozymes from prokaryotes — the advent of culture-independent methods. Front. Microbiol., 12, 630013.
  3. Mesbah, N. M. (2022). Industrial biotechnology based on enzymes from extreme environments. Front. Bioeng. Biotechnol., 10, 870083.
  4. Abdul Rehman, Y., et al. (2026). Molecular adaptations and engineering of extremophiles for synthetic biology and biotechnological applications. Front. Microbiol., 17, 1754802.
  5. Cline, J., Braman, J. C., & Hogrefe, H. H. (1996). PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res., 24, 3546–3551.
  6. Abdulsalam, H., et al. Radiation-resistance in alternative energy systems: a critical approach to microbial fuel cells adapted for extreme environments. Eur. J. Phys. Funct. Mater., 10(1), 6–24.
  7. Sharma, G., et al. (2026). Extremophilic exopolysaccharides: diversity, biosynthesis, and industrial applications. Environmental Technology Reviews, 15(1), 1–10.

Beyond writing

Talks & Interviews

Hosting researcher interviews, guest-speaking on science communication, and teaching PhD-readiness skills.

Host, PhD Talk Show — BioPatrika

Communications Specialist, BioPatrika (2023) — long-form interviews with researchers and faculty about their work and career paths. No longer active in this role.

Speaking & Teaching

Beyond Research webinar flyer featuring Sugandha Asthana, Session 78, Journey of a Researcher

Guest speaker, "Journey of a Researcher" — Session 78 of Biopractify's "Beyond Research" webinar series.

Online webinar · June 2026

Sugandha Asthana
Dr. Sugandha Asthana PhD in Biotechnology, Amity University
PhD Bootcamp LMS roadmap, 4-week learning flow, Aimlay Academy

Designed and delivered a 4-week PhD Bootcamp curriculum for Aimlay Academy's LMS — covering research fundamentals, entrance-exam preparation, and interview readiness for prospective doctoral candidates.

Aimlay Academy · faculty (guest)

Guest reviewer — NextGen Biology International Newsletter

Edited & reviewed articles

Two pieces I reviewed before publication. Written and credited to their actual authors below.

Beyond Trial & Error: How CRISPR and Precision Medicine Are Fighting Triple-Negative Breast Cancer

Written by Aditya A & Lena Shibu · 32nd Edition, NextGen Biology International Newsletter

Guest reviewer Read on LinkedIn →

Rhythm in the Vasculature: How Mechanotransduction Decodes Language

NextGen Biology International Newsletter · author credited on LinkedIn

Guest reviewer Read on LinkedIn →

Both links go to LinkedIn, which can show a sign-in wall to logged-out visitors. Send me a couple of real sentences from each piece and I'll add a proper on-page synopsis here so readers aren't blocked from seeing what they're about.